ESC 365 - Mechanisms and therapy of diaphragmatic weakness.

HFA Premium Access

Mechanisms and therapy of diaphragmatic weakness.

Session: How should comorbidities in heart failure be treated?

Topic: Co-morbidities

Speaker: Doctor A. Lacampagne (Montpellier, FR)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Doctor Alain Lacampagne

Laboratory for Cardiovascular Physiology of Montpellier, Montpellier (France)

1 presentation

0 follower

3 more presentations in this session

How to approach COPD in heart failure.

Speaker: Professor M. Lainscak (Murska Sobota, SI)

All about alcohol and the liver in heart failure.

Speaker: Professor S. von Haehling (Goettingen, DE)

The problems of cachexia, sarcopenia and frailty in heart failure: treatment options.

Speaker: Professor S. Anker (Berlin, DE)

Access the full session

How should comorbidities in heart failure be treated?

Speakers: Doctor A. Lacampagne, Professor M. Lainscak, Professor S. von Haehling, Professor S. Anker

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by